Penn Medicine Abramson Cancer Center
T

Precision Medicine and IO Have Arrived for Cholangiocarcinoma: An Overview of Recent Approvals and Ongoing Clinical Trials

By Penn Medicine Abramson Cancer Center FEATURING Thomas Karasic
By Penn Medicine Abramson Cancer Center FEATURING Thomas Karasic
284 views
May 25, 2023
0 Comments
Login to view comments. Click here to Login

Featured Video

15:07
Exelixis

Safety and Efficacy Data of a TKI Monotherapy in HCC

Feat. J. Mizrahi

Featured Video

10:25
Exelixis

Explore the mechanism of Action of a TKI in HCC

Feat. W. Keiser

Related Content

AUTOPLAY
57:44
Vogl, NY

Vogl,NY on How to Ask Good Questions at Medical Meetings

Feat. S. Vogl
22:55
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Summary: "GI Key Studies Including PROSPECT, HERIZON…

Feat. R. Kim, R. Mehta
27:37
ASCO GI 2023 Conference Coverage

ASCO GI 2023 Expert Panel Discussion: Practice-Changing Updates

Feat. N. Uboha, A. Turk, K. Spencer, M. Cecchini
27:04
Fengting Yan

Cancer Screening Molecular Tools

06:47
UCSF School of Medicine

Tumor-Agnostic Efficacy & Safety of Selpercatinib in RET Fusion+…

Feat. H. Kang
17:50
AdventHealth

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

Feat. G. Sonpavde
13:47
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Expanding the Benefit - Dabrafenib/Tramet…

Feat. V. Subbiah
16:40
Moffitt Cancer Center

Year in Review: Hepatobiliary Cancers

Feat. R. Kim, T. Biachi
07:27
Jason Levy

Opus One: Final Results - RFA in Axial Skeleton

06:03
Total Health

2024 Updates on Targeted Approaches for GI Cancers and New Data in N…

Feat. A. Grothey
28:25
Integrity Continuing Education

Extensive, Liver-Only Metastases From Colon Cancer: Case Presentatio…

Feat. V. Lee, E. Christenson, N. Bhagat, E. Winslow
12:04
Arndt Vogel

Pemigatinib in Cholangiocarcinoma: Targeting FGFR2 Fusions

08:24
Yale Cancer Center

GI Oncology Year in Review: Hepatobiliary Cancers

Feat. P. Kunz
14:54
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Summary: "HCC and Cholangiocarcinoma Mini Orals Highl…

Feat. L. Rimassa
14:33
Insights from 2023 ESMO Annual Meeting

Personalized Medicine and Targeted Agents for Biliary Tract Cancer

Feat. L. Rimassa
22:33
Integrity Continuing Education

Oligometastatic Colon Cancer to Liver: Case Presentation and Panel D…

Feat. V. Lee, R. Kumar, N. Bhagat, E. Winslow
09:03
Integrity Continuing Education

Combined Hepatocellular-Cholangiocarcinoma: Diagnosis and Management

Feat. J. Birkness-Gartman
04:39
Insights from 2024 ASCO® GI Annual Meeting

ASCO® GI 2024 Insights: "PROOF 301 Trial - Oral FGFR Inhibitor …

Feat. G. Abou-Alfa
29:25
Young Chae

Hyperprogression in Cancer Treated With Immunotherapy

12:21
2023 Johns Hopkins Updates in Gastrointestinal Cancers

Great Debate: Neoadjuvant vs. Adjuvant Therapy for High-Risk BTC - P…

Feat. M. Yarchoan